AI assistant
Sending…
RESMED INC — Director's Dealing 2018
Mar 2, 2018
30071_dirs_2018-03-02_bbec14de-4298-4599-aaac-50a1a4d3b465.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-03-01
Reporting Person: Hollingshead James (President, Sleep Business)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-03-01 | ResMed Common Stock | S | 600 | $94.01 | Disposed | 60540 | Direct |
Footnotes
F1: The transaction was conducted under a Rule10b5-1 Plan.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29